à pointes - meaning and definition. What is à pointes
Diclib.com
ChatGPT AI Dictionary
Enter a word or phrase in any language 👆
Language:     

Translation and analysis of words by ChatGPT artificial intelligence

On this page you can get a detailed analysis of a word or phrase, produced by the best artificial intelligence technology to date:

  • how the word is used
  • frequency of use
  • it is used more often in oral or written speech
  • word translation options
  • usage examples (several phrases with translation)
  • etymology

What (who) is à pointes - definition

TYPE OF ABNORMAL HEART RHYTHM THAT CAN LEAD TO SUDDEN CARDIAC DEATH
Torsade de pointes; Torsades de Pointes; Torsades; Torsades de pointe; Torsade; R on T; R-on-T; R on T phenomenon; R-on-T phenomenon; R on T VES; R-on-T PVC; Torsades des pointes
  • ECG]] showing a TdP patient being shocked by an [[implantable cardioverter-defibrillator]] back to their baseline [[cardiac rhythm]]

torsade de pointes         
[t?:?s?:d d?'pwa orsade de pointest]
¦ noun Medicine a form of tachycardia in which the heart's electrical activity varies cyclically.
Origin
1960s: Fr., lit. 'twist of spikes' (with ref. to the characteristic electrocardiogram produced).
Torsade         
·add. ·noun A twisted cord; also, a molded or worked ornament of similar form.
Pointe-à-Bouleau, New Brunswick         
HUMAN SETTLEMENT IN NEW BRUNSWICK, CANADA
Pointe-a-Bouleau, New Brunswick
Pointe-à-Bouleau was a settlement in Gloucester County, New Brunswick. It is now part of the Regional Municipality of Grand Tracadie–Sheila.

Wikipedia

Torsades de pointes

Torsades de pointes, torsade de pointes or torsades des pointes (TdP) (, French: [tɔʁsad də pwɛ̃t̪], translated as "twisting of peaks") is a specific type of abnormal heart rhythm that can lead to sudden cardiac death. It is a polymorphic ventricular tachycardia that exhibits distinct characteristics on the electrocardiogram (ECG). It was described by French physician François Dessertenne in 1966. Prolongation of the QT interval can increase a person's risk of developing this abnormal heart rhythm, occurring in between 1% and 10% of patients who receive QT-prolonging antiarrhythmic drugs.